We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure (ERADICATE-HF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03416270
Recruitment Status : Unknown
Verified May 2018 by David Z.I. Cherney, University Health Network, Toronto.
Recruitment status was:  Not yet recruiting
First Posted : January 31, 2018
Last Update Posted : May 2, 2018
Sponsor:
Collaborators:
University Medical Center Groningen
Merck Sharp & Dohme LLC
University of Toronto
Toronto General Hospital
Information provided by (Responsible Party):
David Z.I. Cherney, University Health Network, Toronto

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : March 1, 2021
Estimated Study Completion Date : March 1, 2021